Alnylam Pharmaceuticals
Develops RNAi therapeutics to treat rare and common diseases.
H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.
biotechpharmaceuticals
Company facts
- Founded
- 2002
- Employees
- 2,500
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: ALNY
Open positions
83 jobs
11 hours ago
Director, Clinical Research- Benign Hematology
New North America, UKFull-time Cambridge, MA, Philadelphia, PA, Maidenhead, England
Overview Alnylam Pharmaceuticals is seeking an imaginative physician drug developer, with the flexibility and confidence to work across diseases within the neurology and hematology therapeutic area. This role includes…
5 views 2 days ago
Senior Director, Head of PV Science
Open 51d HybridNorth AmericaFull-timeC-level H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.
United States
Cambridge, MA or Philadelphia, PAOverview Alnylam is the industry leader in the translation of RNA interference (RNAi) into a new class of innovative medicines with the potential to address the unmet needs of patients with debilitating diseases.…
AI Analytics Corrective Action Process Improvement